home / stock / mdgl / mdgl articles


MDGL Articles, Madrigal Pharmaceuticals Inc. - From 03/14/24

Stock Information

Company Name: Madrigal Pharmaceuticals Inc.
Stock Symbol: MDGL
Market: NASDAQ
Website: madrigalpharma.com

Menu

MDGL MDGL Quote MDGL Short MDGL News MDGL Articles MDGL Message Board
Get MDGL Alerts

News, Short Squeeze, Breakout and More Instantly...

Madrigal Pharmaceuticals Announces FDA Approval of Rezdiffra™ (resmetirom) for the Treatment of Patients with Noncirrhotic Nonalcoholic Steatohepatitis (NASH) with Moderate to Advanced Liver Fibrosis | Benzinga

Rezdiffra becomes the first and only medication approved by the FDA for the treatment of NASH (also known as "MASH") Accelerated approval was bas...

Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Shares of Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the company reported fourth-quarter financial re...

Madrigal Pharmaceuticals Appoints Mardi C. Dier as Chief Financial Officer | Benzinga

CONSHOHOCKEN, Pa., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pu...

Madrigal Pharmaceuticals Announces Additions to Its Leadership Team | Benzinga

CONSHOHOCKEN, Pa., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pu...

Liver Disease Player 89Bio Downgraded: Analyst Sees Short-Term Uncertainties In Fatty Liver Drug Development | Benzinga

RBC Capital Markets downgraded 89Bio Inc (NASDAQ:ETNB), a clinical-stage biopharmaceutical company focused on developing and commerc...

Madrigal Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference | Benzinga

CONSHOHOCKEN, Pa., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pu...

Why Comtech Telecommunications Shares Are Trading Lower By Over 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session | Benzinga

Shares of Comtech Telecommunications Corp. (NASDAQ: CMTL) moved lower during Friday’s session following weak quarterly earnings. Comtech Tele...

Can Weight-Loss Drug Ozempic Tip The Scales For Tema's New Healthcare ETF? | Benzinga

Tema, the exchange-traded fund platform, has launched a healthcare ETF focused on companies that research and treat cardiovascular disease and cond...

Madrigal Pharmaceuticals Appoints Ronald Filippo as Chief Information Officer | Benzinga

CONSHOHOCKEN, Pa., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pu...

Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | Benzinga

CONSHOHOCKEN, Pa., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pu...

Previous 10 Next 10